Background

Mr. J. Martin Carroll, also known as Marty, served as the Chief Executive Officer and President of Boehringer Ingelheim GmbH. Mr. Carroll served as the Head of Corporate Strategy and Development for Boehringer Ingelheim's U.S. operations from 2003 to 2011. He served as the Chief Executive Officer and President of Boehringer Ingelheim in the USA from 2003 to 2011. He served as Global Head of Strategy and Development for Boehringer Ingelheim (Germany) from 2009 to 2012. ... He served as the President and Chief Executive Officer of Boehringer Ingelheim Corporation from August 2002 to 2011 and of Boehringer Pharmaceuticals, Inc. He served as the Chief Executive Officer and President of Boehringer Ingelheim Pharmaceuticals Inc., a subsidiary of Boehringer Ingelheim Corporation since 2002. He served as the Chief Executive Officer and President of Boehringer Ingelheim, Inc. During his tenure at BI, he was instrumental in guiding the launch of Spiriva(R) and Pradaxa(R) in the U.S. from 1976 to 2001 including Manufacturing, International (Japan), and Marketing and Sales. He served as Manufacturing, International (Japan), and Marketing and Sales. He played a major role in working with the BI board of Managing Director's to develop strategic approaches for a number of BI businesses, focusing mainly on pharmaceuticals. He served in various positions with Merck & Co., a pharmaceutical products company including Vice President of Marketing, Senior Vice President of Sales, Senior Vice President of Managed Care Marketing and Sales and Executive Vice President of Customer Marketing and Sales of the U.S. Human Health Division for more than 25 years. He has more than 35 years of executive level experience in the pharmaceutical industry. He has been an Independent Director at TherapeuticsMD, Inc. since March 18, 2015. He serves as a Director of Boehringer Ingelheim Corporation. He has been an Independent Director of Mallinckrodt public limited company since June 28, 2013. He served as a Director of VIVUS Inc. from May 13, 2013 to September 20, 2014. He served as a Director of Durata Therapeutics, Inc. since August 2014. He served as a Director of Accredo Health, Incorporated since January 2004. He served as a Director of PhRMA. 1972 to 1976, he served in the United States Air Force. He serves as a Member of the Board of Trustees of Gwynedd-Mercy College. Mr. Carroll received a Bachelor of Arts in Accounting & Economics from the College of the Holy Cross (Massachusetts) and an M.B.A. degree from Babson College (Massachusetts).

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.